|
業務類別
|
Biotechnology |
|
業務概覽
|
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company isdeveloping two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery. |
| 公司地址
| 27061 Aliso Creek Road, Suite 100, Aliso Viejo, CA, USA, 92656 |
| 電話號碼
| +1 949 284-6904 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.spyglasspharma.com |
| 員工數量
| 65 |
| Dr. Jean-Frederic Viret, PhD |
Chief Financial Officer and Principal Accounting Officer |
-- |
26/03/2026 |
| Mr. Glenn Sussman |
Chief Technology Advisor |
-- |
26/03/2026 |
| Mr. Patrick H. Mooney |
Chief Executive Officer and Director |
美元 444.54K |
26/03/2026 |
| Dr. Malik Y. Kahook, M.D. |
Executive Chairman of the Board, President and Chief Medical Officer |
-- |
26/03/2026 |
| Mr. James Robert Dennewill, Jr |
Chief Operating Officer |
-- |
26/03/2026 |
| Dr. Chetan Pratap Pujara, PhD |
Chief Research and Development Officer |
美元 355.25K |
26/03/2026 |
|
|
| Mr. Kirk Nielsen |
Independent Director |
26/03/2026 |
| Mr. Habib Joseph Dable |
Director |
09/02/2026 |
| Dr. Zachary Scheiner, PhD |
Independent Director |
26/03/2026 |
| Dr. Michael Dybbs, PhD |
Independent Director |
26/03/2026 |
| Ms. Elizabeth G. O’Farrell |
Independent Director |
26/03/2026 |
| Mr. Patrick H. Mooney |
Chief Executive Officer and Director |
26/03/2026 |
| Dr. Malik Y. Kahook, M.D. |
Executive Chairman of the Board, President and Chief Medical Officer |
26/03/2026 |
| Dr. Ali Behbahani, M.B.A.,M.D. |
Independent Director |
26/03/2026 |
| Mr. Geoff Pardo |
Independent Director |
26/03/2026 |
| Mr. Bilal Arshad Khan |
Independent Director |
26/03/2026 |
|
|
|
|
